Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide.
about
Treating malignant glioma in Chinese patients: update on temozolomideRadiation therapy for older patients with brain tumorsγ-secretase inhibitor DAPT sensitizes t-AUCB-induced apoptosis of human glioblastoma cells in vitro via blocking the p38 MAPK/MAPKAPK2/Hsp27 pathwayReview: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapiesAssessment and treatment relevance in elderly glioblastoma patients.Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).Management of elderly patients with gliomasRadiotherapy plus concurrent or sequential temozolomide for glioblastoma in the elderly: a meta-analysis.Computer-extracted MR imaging features are associated with survival in glioblastoma patients.Predictive value of MGMT promoter methylation status in Asian and Caucasian patients with malignant gliomas: a meta-analysisMGMT testing allows for personalised therapy in the temozolomide era.Toxicity and outcome of radiotherapy with concomitant and adjuvant temozolomide in elderly patients with glioblastoma: a retrospective study.The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials.Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy.Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas.Patterns of failure after multimodal treatments for high-grade glioma: effectiveness of MIB-1 labeling indexAssociation between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma.Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma.Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy.Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients.Temozolomide does not impair gene therapy-mediated antitumor immunity in syngeneic brain tumor models.Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience.Glioblastoma: approach to treat elderly patients.Progress on molecular biomarkers and classification of malignant gliomas.Treating glioblastoma in the elderly.Radiation therapy for older adults with glioblastoma: radical treatment, palliative treatment, or no treatment at all?Molecularly based management of gliomas in clinical practice.Glioblastoma care in the elderly.The predictive but not prognostic value of MGMT promoter methylation status in elderly glioblastoma patients: a meta-analysis.Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.Is the prognostic significance of O6-methylguanine- DNA methyltransferase promoter methylation equally important in glioblastomas of patients from different continents? A systematic review with meta-analysis.The apoptosis-resistance in t-AUCB-treated glioblastoma cells depends on activation of Hsp27.The prognosis of MGMT promoter methylation in glioblastoma patients of different race: a meta-analysis.MGMT promoter methylation and correlation with protein expression in primary central nervous system lymphoma.Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers.The Clinical Significance of O6-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis.Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue.IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy.Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients.
P2860
Q26863755-B73411F9-9FAB-4957-87DA-72CFB3452A9DQ33815025-914E5BA1-FC6E-4A9E-B0A2-B1ECF4779500Q33861921-8DBB679C-C83C-4C5A-8CDB-FDF9E5936858Q33925544-DD2A6030-F453-40D3-AB69-2D8E7415378DQ34359650-8EB329E1-3035-455B-86B9-043D69BD7CDCQ34478948-07264ABD-7F51-419B-96E5-9397D61F9EA5Q34641001-FD29B21E-7F6E-4705-B242-E8DE7AF5C07CQ35004927-13364608-15D7-412C-8210-C29B0F9A2831Q35230527-8E9F5D7D-5017-471F-9A4D-D6B6E954F1F1Q35679476-72DBC409-73CE-4E6D-9675-E9EFB78F4803Q35827916-3A4D39DB-E0FD-49C7-91EF-F00F6690E710Q35943909-AB5A0A40-94FE-4175-9588-A5495B100F7FQ36299167-39F294D7-ACB8-450B-8EB7-566A99B2A389Q36500074-A4FAFBD8-39D1-487A-930C-023E1B2E9969Q36552798-53573D9C-96E2-481D-B8C5-7458717AB358Q36603152-846A352C-11D2-4EE9-90CE-5DD071472AA3Q36642211-44DBC4B3-F297-4C4A-836E-3E205F589CF2Q36665022-63559AA0-128A-4A30-9635-9709ABB69008Q37191560-9D8963D8-ECDA-4183-AD55-9BFE02E263B1Q37226536-823D5A4B-5FBD-4117-9B0E-7E578E677C2DQ37526270-AA5FB6F7-5921-426F-93AF-CCAB1052A1A4Q37647868-0D901473-5EBA-4EA4-8A52-187D5B96BB61Q37959367-99C941B2-9DED-4325-B5EB-E17AF59CCEA1Q38079529-953E6894-8615-4989-8D92-E969C42D44F8Q38107462-3E96B077-D1DD-4E42-94F4-ECB51B9557D6Q38233427-184384E6-D949-4212-B3F0-1EC691D82260Q38237311-6542CA2B-F28F-4E9E-A89B-E5489CF77817Q38551010-2D9B7452-C061-452F-B644-878D6E1E99B9Q38653138-16007D29-9A1F-4694-981C-76F0762737CDQ39266259-A823F971-2950-4F2D-B03B-25D255F09DF6Q41435886-B6A3DED9-E972-4EA5-A3C7-D02E803562E6Q42364418-9845AAD5-C95D-49DA-8F3F-851DA3EE4A3DQ44079969-B8705000-E5F9-4EAE-9186-E037BD5A8BB1Q45835773-A2B5C603-F0B0-431D-87A2-A0EA376A15C1Q48656685-FA96A748-C732-453C-8164-7E650EC45DD5Q48910170-5F7A69B7-3A83-4157-89CE-DF510905E23EQ52606179-656D54E9-80F0-4896-A13A-1643986AF5D3Q52715248-DB3C3549-601E-4568-904C-2EBAF7A4139DQ55460980-07742C68-025E-47FF-9249-7F47B1320F6FQ55461155-2B3AEA95-EFBB-4C47-89E2-D5EB5EC91C8B
P2860
Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Correlation between O6-methylg ...... ant and adjuvant temozolomide.
@en
Correlation between O6-methylg ...... ant and adjuvant temozolomide.
@nl
type
label
Correlation between O6-methylg ...... ant and adjuvant temozolomide.
@en
Correlation between O6-methylg ...... ant and adjuvant temozolomide.
@nl
prefLabel
Correlation between O6-methylg ...... ant and adjuvant temozolomide.
@en
Correlation between O6-methylg ...... ant and adjuvant temozolomide.
@nl
P2093
P2860
P50
P1476
Correlation between O6-methylg ...... ant and adjuvant temozolomide.
@en
P2093
F Buttarelli
F Giangaspero
G Lanzetta
Giuseppe Minniti
R Maurizi Enrici
S Scarpino
P2860
P2888
P304
P356
10.1007/S11060-010-0324-4
P577
2010-08-05T00:00:00Z